Relmada Therapeutics Inc. (RLMD) Statistics & Valuation Metrics - Stocknear

Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
1.65
0.28 (20.44%)
At close: Sep 05, 2025, 3:59 PM
1.63
-1.13%
After-hours: Sep 05, 2025, 07:50 PM EDT

Relmada Therapeutics Statistics

Share Statistics

Relmada Therapeutics has 33.19M shares outstanding. The number of shares has increased by 10% in one year.

33.19M
10%
10%
20.45%
26.44M
14,680
2.13%

Short Selling Information

The latest short interest is 478.39K, so 1.44% of the outstanding shares have been sold short.

478.39K
1.44%
1.47%
2.66

Valuation Ratios

The PE ratio is -0.2 and the forward PE ratio is -1.38. Relmada Therapeutics's PEG ratio is 0.01.

-0.2
-1.38
0
5.5
0.44
-0.3
0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Relmada Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.

4.45
4.45
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-4.7M
17
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 175% in the last 52 weeks. The beta is 0.74, so Relmada Therapeutics's price volatility has been higher than the market average.

0.74
175%
0.7
0.51
84.94
687,837

Income Statement

n/a
n/a
-83.89M
-79.98M
-79.98M
-79.98M
-2.65
Full Income Statement

Balance Sheet

The company has 3.86M in cash and 0 in debt, giving a net cash position of 3.86M.

3.86M
n/a
n/a
-640.88M
21.12M
15.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.76M and capital expenditures 0, giving a free cash flow of -51.76M.

-51.76M
n/a
-51.76M
-1.72
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RLMD is $1, which is -39.4% lower than the current price. The consensus rating is "Hold".

$1
-39.4%
Hold
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Sep 30, 2019. It was a backward split with a ratio of 1:4.

Sep 30, 2019
backward
1:4

Scores

-55.46
1